Media Summary: This webinar is aimed at providing an introduction and overview of Identifying the appropriate patient population for an experimental therapy is an essential yet challenging task in JNOLive July 14, 2020 Ramez Kouzy, MD, Joseph Abi Jaoude, MD, and Ethan Ludmir, MD join JAMA Network Open Digital ...

Multiplicity In Clinical Studies - Detailed Analysis & Overview

This webinar is aimed at providing an introduction and overview of Identifying the appropriate patient population for an experimental therapy is an essential yet challenging task in JNOLive July 14, 2020 Ramez Kouzy, MD, Joseph Abi Jaoude, MD, and Ethan Ludmir, MD join JAMA Network Open Digital ... Outline This online course gives a comprehensive overview of traditional This Stats, STAT! animated video explores interim analyses in For more information on the software tools featured in this online training course, please visit

... on Cardiovascular Pharmacotherapy “All About Presented by Seuli Brill, MD, Director of Inflation of type I error rate from a Multiple Testing problem is commonly referred to as In this video, Dr. Dan provides an overview of

Photo Gallery

Introduction to Multiplicity in Clinical Trials
Multiplicity in Clinical Studies
NHLBI ICTR Short Video #2, Subgroup Analyses in Clinical Trials
Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019
Key Multiplicity Issues in Clinical Trials I (Introduction)
Key Multiplicity Issues in Clinical Trials I (Module A)
How Interim Analyses Work | NEJM Evidence
Adjustments for Multiple Testing? When and How to Handle Multiplicity - May 2018 [Sample]
Key Multiplicity Issues in Clinical Trials (Part I): Introduction
Key Multiplicity Issues in Clinical Trials (Part II): Introduction
Key Multiplicity Issues in Clinical Trials I (Module B)
How to interpret clinical trial data – Examples from recent clinical trials
View Detailed Profile
Introduction to Multiplicity in Clinical Trials

Introduction to Multiplicity in Clinical Trials

This webinar is aimed at providing an introduction and overview of

Multiplicity in Clinical Studies

Multiplicity in Clinical Studies

Link to article: https://www.nejm.org/doi/full/10.1056/NEJMra1709701.

NHLBI ICTR Short Video #2, Subgroup Analyses in Clinical Trials

NHLBI ICTR Short Video #2, Subgroup Analyses in Clinical Trials

Identifying the appropriate patient population for an experimental therapy is an essential yet challenging task in

Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019

Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019

JNOLive | July 14, 2020 Ramez Kouzy, MD, Joseph Abi Jaoude, MD, and Ethan Ludmir, MD join JAMA Network Open Digital ...

Key Multiplicity Issues in Clinical Trials I (Introduction)

Key Multiplicity Issues in Clinical Trials I (Introduction)

Outline This online course gives a comprehensive overview of traditional

Key Multiplicity Issues in Clinical Trials I (Module A)

Key Multiplicity Issues in Clinical Trials I (Module A)

Outline This online course gives a comprehensive overview of traditional

How Interim Analyses Work | NEJM Evidence

How Interim Analyses Work | NEJM Evidence

This Stats, STAT! animated video explores interim analyses in

Adjustments for Multiple Testing? When and How to Handle Multiplicity - May 2018 [Sample]

Adjustments for Multiple Testing? When and How to Handle Multiplicity - May 2018 [Sample]

A

Key Multiplicity Issues in Clinical Trials (Part I): Introduction

Key Multiplicity Issues in Clinical Trials (Part I): Introduction

For more information on the software tools featured in this online training course, please visit https://medianasoft.github.io.

Key Multiplicity Issues in Clinical Trials (Part II): Introduction

Key Multiplicity Issues in Clinical Trials (Part II): Introduction

For more information on the software tools featured in this online training course, please visit https://medianasoft.github.io.

Key Multiplicity Issues in Clinical Trials I (Module B)

Key Multiplicity Issues in Clinical Trials I (Module B)

Outline This online course gives a comprehensive overview of traditional

How to interpret clinical trial data – Examples from recent clinical trials

How to interpret clinical trial data – Examples from recent clinical trials

... on Cardiovascular Pharmacotherapy “All About

Pragmatic Clinical Trials

Pragmatic Clinical Trials

Presented by Seuli Brill, MD, Director of

Multiplicity Problem in Clinical Trials and Some Statistical Approaches

Multiplicity Problem in Clinical Trials and Some Statistical Approaches

Inflation of type I error rate from a Multiple Testing problem is commonly referred to as

Key Multiplicity Issues in Clinical Trials I (Module C)

Key Multiplicity Issues in Clinical Trials I (Module C)

Outline This online course gives a comprehensive overview of traditional

Clinical Trials: It’s not just a phase!

Clinical Trials: It’s not just a phase!

This video covers the role of

27 Principles of Clinical Trials

27 Principles of Clinical Trials

In this video, Dr. Dan provides an overview of

Understanding Clinical Trials

Understanding Clinical Trials

This animation explains what

Key Multiplicity Issues in Clinical Trials (Part II): Module F

Key Multiplicity Issues in Clinical Trials (Part II): Module F

Module F. General adaptive